Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2010-03-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Protein-enriched Diet on Body Composition and Appetite
NCT01634048
Isolating and Exploiting the Mechanisms That Link Breakfast and Human Health - Intervention
NCT04417205
Protein Quality on Appetite Control, Reward-driven Eating, & Subsequent Food Intake
NCT02285907
Mycoprotein, Resistance Training, and Hypertrophy
NCT03572127
"Ounce-equivalents" in the Protein Foods Group: Benefits of Quality
NCT03179462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mycoprotein
3 levels of mycoprotein will be consumed
mycoprotein
control protein
3 levels of a control protein will be consumed
control protein
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mycoprotein
control protein
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index (BMI) 25-32kg/m2
* Weight stable over the past 6 months
* No known major illness or eating disorder nor on any medication that may impact on appetite or hormone levels.
* No paracetamol or other analgesic in the previous 48 hours
* A score of \<2.5 in the Dutch Eating Behaviour Questionnaire (DEBQ)
* A score of \<2 in the SCOFF questionnaire
Exclusion Criteria
* Pregnant and lactating women
* Weight variation of greater than 5% in the last 6 months
* Any diagnosed major illness
* Any paracetamol or analgesic intake in the last 48 hours
* Diagnosed eating disorder
* Allergy to mycoprotein or mushrooms
* Regular consumption of Quorn products
* Dislike of any of the test foods or drinks
* A score of \>2.5 in the Dutch Eating Behaviour questionnaire
* A score of 2 or more in the SCOFF questionaire
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Frost
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College NIHR CRF
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bottin JH, Swann JR, Cropp E, Chambers ES, Ford HE, Ghatei MA, Frost GS. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial. Br J Nutr. 2016 Jul;116(2):360-74. doi: 10.1017/S0007114516001872. Epub 2016 May 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRO1332
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.